News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Pre-Clinical (World)
BioBlast Pharma (ORPN) Announces Positive In Vivo Preclinical Proof-Of-Concept Results Of Its Cabaletta Platform In Spinocerebellar Ataxia Type 3 (SCA3) 3/30/2015
Tekmira (TKMR) Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of Apoc3 And ANGPTL3 Genes 3/26/2015
Sangui BioTech International Inc. (SGBI): Series Of Preclinical Trials Concluded Successfully 3/18/2015
Greenovation Biotech GmbH Successfully Completes Preclinical Toxicology Studies Of Alpha - Galactosidase 3/10/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015
Sirona Biochem: Positive Preclinical Toxicology Results For Its SGLT2 Inhibitor Trigger Milestone Payment From Wanbang Biopharmaceuticals 3/4/2015
Addex Therapeutics (ADXN.SW) mGluR2 NAM Demonstrates Protection In Preclinical Model Of Ischemic Neuronal Death 2/19/2015
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs 2/11/2015
Two of Roche (RHHBY)'s Experimental Parkinson's Drugs Caused Lung Toxicity in Monkeys 2/9/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001 1/28/2015
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015
Dry Eye Syndrome: Neuroptis Biotech Successfully Completes The Pre-Clinical Phase For ML7 1/21/2015
Novartis AG (NVS) Researchers Claim to Have Discovered "Fountain of Youth" Drug 1/5/2015
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Admedus HPV Vaccine Heads To The Clinic 11/24/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting 11/13/2014
nanoMR Inc. Lands $21.5 Million Deal 11/7/2014
Ablynx (ABLYF) To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, Alx-0171, At 9th International Respiratory Syncytial Virus Symposium 11/6/2014
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014
Compugen Ltd. (CGEN) Achieves Second Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer AG (BAYZF) 10/14/2014
Kadimastem Received A Quick Response From The FDA: The Development Process For The Stem Cell-Based Drug For ALS Is Expected To Be Significantly Shortened 10/7/2014
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
Cell Reports Publication On The Mechanism Of Action Of NOXXON’s Anti-SDF-1 Spiegelmer® Olaptesed Pegol (NOX-A12) In Preclinical Multiple Myeloma Models 9/26/2014
Sirona Biochem Launches Anti-aging Preclinical Studies 9/23/2014
Novartis AG (NVS) Studies Muscle Atrophy By Sending Mice Into Space 9/23/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations 9/17/2014
GlaxoSmithKline (GSK)'s Experimental Ebola Vaccine Protects Monkeys For 10 Months 9/8/2014
GamaMabs Pharma SA Announces Two Scientific Communications On Its AMHR2 Project 9/4/2014
Sirona Biochem Announces Positive Results In PK Study For Type 2 Diabetes 9/4/2014
Ebola Vaccine Using Immunovaccine Inc.’s DepoVax Proves Highly Efficacious In Non-Human Primate Study 8/25/2014
Stemedica International Announces Pre-clinical Data Of Its Alzheimer’s Study 8/20/2014
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014
Scancell Release: Synergy Of SCIB1 With Checkpoint Inhibitors 8/12/2014
Cannabis Science Inc. Initiates Pre-Clinical Studies On Cannabinoid Formulations In Neurological Diseases Including Sleep Disorders With The Highly Reputable Institute For Health And Science On Ageing - INRCA - In Italy 8/4/2014
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014
BiOptix And Altermune Technologies Present At Drug Analysis 2014 6/27/2014
RedHill Biopharma Ltd. (RDHL) Announces Positive Preliminary Pre-Clinical Data With RHB-104 For The Treatment Of Type 1 Diabetes 6/26/2014
Apitope Progresses Graves' Disease Treatment 6/19/2014
Success In Kadimastem’s First Pre-Clinical Trial For Treatment Of Amyotrophic Lateral Sclerosis (ALS) 6/19/2014
Zealand Pharma  (ZEAL.CO) Presented New Data On Two Novel Peptide Therapeutics From Its Preclinical Diabetes Pipeline At The American Diabetes Association 74th Scientific Sessions 6/17/2014
Five Scientific Communications At The European Academy Of Allergy And Clinical Immunology Congress Further Support DBV Technologies's EPIT™ Disease Modifying Effect 6/11/2014
Cellectis And Accelera (Nerviano Medical Sciences (NervianoMS)) Sign An Agreement To Complete Preclinical Studies Of Cellectis’ Lead Product Candidate UCART19 6/5/2014
Galmed Pharmaceuticals Release: Recently Published Independent Research Supports The Importance Of Reverse Cholesterol Transport On NASH Pathogenesis 6/4/2014
Implandata Successfully Launched Pre-Clinical Studies For New To The World Implantable 24h Extraocular Sensor For Intraocular Pressure Measurement At Glaucoma Patients 6/3/2014
Theralase Technologies Inc. (TLT.V) Discovers Anti-Cancer Memory Response 6/2/2014
Novogen Limited (NVGN) Identifies Highly Active Drug Candidates Against Prostate Cancer 5/27/2014
Da Volterra Presents New Data Supporting DAV132 As A Promising Candidate To Protect The Intestinal Flora And Prevent Severe Clostridium Difficile Infections 5/12/2014
Apitope Initiates Preclinical Development Of Peptide Therapy, ATX-F8-117, To Treat Factor VIII Intolerance 5/7/2014
Albireo’s Lead Compound In Cholestatic Liver Diseases, A4250, Protects Against Bile Acid-Mediated Cholestatic Liver Injury In Mice 4/11/2014
ERYtech Pharma Picks Up A New Candidate For Its Tumor Starvation Pipeline 4/9/2014
Domainex Ltd Programme Shows Great Promise For The Treatment Of Inflammatory Diseases, Such As Chronic Obstructive Pulmonary Disease (COPD) 4/7/2014
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014
Patrys Limited (PAB.AX) PAT-LM1 Advancing To The Clinic 3/24/2014
Novagen, Inc. And CanTx Experimental Drug, Trx-1, Proves Effective In Vivo 3/18/2014
Kymab Announces Publication Of The Kymouse Technology In Nature Biotechnology 3/17/2014
Preclinical Results For Pluristem Therapeutics (PSTI)'s PLX-PAD Cells In Tendon Injury Presented At American Academy of Orthopaedic Surgeons' Annual Meeting 3/12/2014
BioLineRx Ltd. Announces Positive Preclinical Results For Novel Treatment For Chronic Myeloid Leukemia 2/12/2014
Cellectis Grants genOway An Exclusive Sublicense For Its Homologous Recombination Technology In The Field Of Genetically Modified Rodent Models 2/4/2014
GENFIT Corp. (ALGFT): Preclinical Data Support Anti-Cancer Effects Of GFT505 1/29/2014
Novozymes Biopharma Announces New Data Highlighting Potential For Monthly Drug Dosing 1/27/2014
NovoCure Ltd. Enrolls First Patient In Pilot Clinical Trial Of Novottf™ Therapy Plus Gemcitabine For First-Line Treatment Of Advanced Pancreatic Adenocarcinoma 1/24/2014
Clasado And University of Oxford Demonstrate Effect Of Prebiotics On Brain And Gut In Pre-Clinical Study 1/23/2014
NovoCure Ltd. Release: Data Published In Pancreatology Demonstrates Activity Of NovoTTF™ Therapy In Preclinical Models Of Pancreatic Cancer, Alone And In Combination With Chemotherapy 1/7/2014
Galapagos NV (GLPG.BR) Selects Pre-Clinical Candidate For Cystic Fibrosis 12/16/2013
Evotec AG (EVTG.F): Results Of Pre-Clinical Studies Lead To Reduction In Revenues, Nevertheless Profitable And More Than EURO 90 M Cash For 2013 Confirmed 12/13/2013
Evotec AG (EVTG.F) Receives Pre-Clinical Milestone As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 12/10/2013
Neuroptis Biotech Announces The Preclinical Results For Its Dry Eye Product ML7 11/12/2013
AM-Pharma Holding BV Presents Positive Data From recAP Preclinical Study at American Society of Nephrology Meeting 11/8/2013
"New" Infectious Diseases: Clinical Tests on Innovative Themis Vaccine 11/7/2013
AIMM Therapeutics' Pre-Fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development 11/4/2013
Ablynx (ABLYF) to Present Pre-clinical Proof-of-Concept Data on ALX-0761 at American College of Rheumatology 10/28/2013
S-TARget Achieves Clinical Proof of Concept for Allergy Vaccine SG100 in Asthmatic Non-Human Primates 10/10/2013
Medivir AB (MVIRb.F): MIV-247 Has Been Selected as a Candidate Drug and Enters Development for the Treatment of Neuropathic Pain 10/10/2013
Compugen Ltd. (CGEN) Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal Model 10/9/2013
Addex Therapeutics (ADXN.SW) ADX71441 Dose Dependently Reduced PMP22 Expression Comparable to Baclofen in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 10/3/2013
Zealand Pharma  (ZEAL.CO) Presents New Preclinical Data on its GLP-1-Gastrin Dual Agonist, Which Shows Potential as a Novel Approach for the Treatment and/or Prevention of Type 2 Diabetes 9/26/2013
Compugen Ltd. (CGEN) Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types Involved in Tumor Progression 9/17/2013
PRECOS Highlights Latest Advances in PDX Modelling for Oncology Drug Discovery to Increase Effectiveness of Drugs for Cancer Patients 9/13/2013
Karo Bio AB Receives Funding From the National MS Society to Develop ERbeta Agonists for Treatment of Progressive Multiple Sclerosis 9/12/2013
Alcobra (ADHD)'s Pre-Clinical Fragile X Study for MG01CI Shows Significant Positive Results 9/10/2013
Chronic Treatment With Addex Therapeutics (ADXN.SW) Dipraglurant Rescues Impairment of Long-Term Synaptic Plasticity in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 9/4/2013
Coffee and Tea May Contribute to a Healthy Liver, Duke-NUS Graduate Medical School Study 8/16/2013
Rib-X Pharmaceuticals, Inc. Presents Data Demonstrating Potent In Vitro Activity of Delafloxacin Against Drug-Resistant Gonorrhea 7/16/2013
VBL Therapeutics Discloses Data About VB-201 Novel Mechanism and Pre-Clinical Efficacy in Atherosclerosis 7/8/2013
Cellectis Announces Groundbreaking in Vivo Proof of Concept Testing of Their Flagship UCART19 Product for Curative Therapy of Leukemia 7/8/2013
Pluristem Therapeutics (PSTI)'s Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE 6/20/2013
TG Therapeutics, Inc. (MHA) Announces Presentation of Pre-Clinical Data on the Combination of TG-1101 and TGR-1202 at the International Conference on Malignant Lymphoma, Lugano, Switzerland 6/20/2013
Novartis AG (NVS) Ramps Up Alzheimer's Drug Pursuit as Rivals Fail 5/24/2013
Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program 5/23/2013
H. Lundbeck A/S (LUN.CO) Release: Vortioxetine, a New Multimodal Agent in Development for the Treatment of Major Depression, Shows Effects on Cognitive Function in Several Preclinical Animal Models 5/22/2013
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) and Roche (RHHBY)'s Human Immune-Boosting Cancer Drugs Seen Extending Lives 5/15/2013
Pluristem Therapeutics (PSTI) Release: Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia 5/13/2013
Starpharma Holdings Ltd's Dendrimer a Potential Viral Conjunctivitis Treatment 5/13/2013
Addex Therapeutics (ADXN.SW) Reports that Dipragluant Demonstrated Dose-Dependent mGlu5 Receptor Occupancy in a Non-Human Primate PET Study 5/1/2013
Evotec AG (EVTG.F): New Hormone to Treat Diabetes Published in "Cell" 4/26/2013
NicOx SA (COX.PA) Release: Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented at Muscular Dystrophy Association Scientific Conference 4/24/2013
Addex Therapeutics (ADXN.SW) Dipraglurant Normalizes Striatal Cholinergic Dysfunction in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 (DYT1) 4/18/2013
Data on SEEK's Novel Immunotherapy for HIV Published in Virology Journal Antibody Treatment for HIV 4/16/2013
Innate Pharma (IPH.PA ) Presents New Data for Proprietary Programs Targeting TLR3 and KIR3DL2 4/12/2013
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100 4/8/2013
Spirogen Ltd. and Bioatla Present Positive Data on Next-Generation Warheads in ADCS Against Cancer 4/8/2013
Successful Vaccine Developments at Themis Bioscience, Pasteur Institute Technology Proves Its Effective Potential 3/27/2013
Proteome Sciences PLC (PRM.L): Developments in Alzheimer's Disease 3/18/2013
GENFIT Corp. (ALGFT) Release: TGFTX1 Program: Successful Identification of Proprietary ROR?t Ligands for the Treatment of Auto-Immune Diseases 3/13/2013
RegeneCure's Membrane Implant Shows 40% Accelerated Healing Time of Severe Bone Fractures in Pet Clinical Study 3/12/2013
PRANA Biotechnology (PRAN)'s PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells 3/6/2013
Starpharma Holdings Ltd Release: Dendrimers Improve Anticancer Efficacy in Lung Metastasis Model 3/4/2013
BioLineRx Ltd.'s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company's Main Therapeutic Pipeline as BL-9010 2/28/2013
VIB: New Angle to Combat Malignant Brain Tumors in Children 2/28/2013
Roche (RHHBY) Research Sheds Light on Improving Neurological Deficits in Mouse Model of Down Syndrome 2/27/2013
Circassia Limited's Cat Allergy Treatment Shows Sustained Symptom Improvement 2/25/2013
Anergis Presents Preclinical Data of its Ragweed Allergy Vaccine Candidate AllerR 2/21/2013
Orion Corporation Release: Promising Preclinical and Phase I Data of a New Generation Androgen Receptor (AR) Inhibitor, ODM- 201, Presented at American Society of Clinical Oncology GU 2013 Symposium 2/15/2013
Mireven Announces Positive In-Vitro Results for miRNA-7-5p in Melanoma 2/12/2013
BioDiem Ltd. (BDM.AX) Progresses to Proof-of-Concept Testing of BDM-I Antimicrobial Effect Against Parasites 2/8/2013
BioDiem Ltd. (BDM.AX)'s Antimicrobial Tested as Treatment for TB, Fungal Infections, in National Institutes of Health (NIH) Research Program 2/1/2013
Addex Therapeutics (ADXN.SW) Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia 1/29/2013
Cellmid Records Positive Data in Midkine Antibody Study in Kidney Disease 1/24/2013
Open Monoclonal Technology and Recombinant Antibody Technology Announce OmniRa™ Scientific Publication 1/22/2013
BrainStorm Cell Therapeutics Inc. Establishes Safety of Repeat Doses of NurOwn in Mice; Pre-clinical Study Conducted at GLP-Compliant Harlan Laboratories, Inc. 1/10/2013
Addex Therapeutics (ADXN.SW) Announces Positive Data With ADX71441 in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 1/7/2013
AMS Biotechnology (AMSBIO) Release: Integrating Extracellular Matrix Into 3D Spheroid Culture for a High Throughput Cell Invasion Assay 12/21/2012
AMS Biotechnology (AMSBIO) Researchers Respond Enthusiastically to Alvetex 3D Cell Culture 12/14/2012
BiondVax Pharmaceuticals' Universal Influenza Vaccine M-001 Significantly Enhances the Efficacy of the Human Pandemic H5N1 Bird Flu Vaccine 12/13/2012
Journal of Huntington's Disease Publishes Benefits of PRANA Biotechnology (PRAN)'s PBT2 12/13/2012
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma 12/13/2012
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma 12/11/2012
PRANA Biotechnology (PRAN) Release: Metal Hypothesis for Alzheimer's, Huntington and Other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium 12/5/2012
The Staby® Technology From Delphi Genetics Efficiently Applied to DNA-Vaccine 12/3/2012
AMSilk Release: Silicone Breast Implants With Spider Silk-Based Coating Show Reduced Side-Effects in Preclinical Studies 11/30/2012
Galapagos NV (GLPG.BR) Discovers Novel Class of Antibiotics 11/26/2012
Poor Sleep Can Lead to Schizophrenia Symptoms, University of Bristol Study 11/15/2012
"Calm Down" Genes Treat Epilepsy in Rats, University College London Study 11/13/2012
BioLineRx Ltd. Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 American Society of Hematology Annual Meeting 11/7/2012
Basilea Pharmaceutica (BSLN.SW)'s Novel Oncology Drug Candidate BAL101553: Data Presented at International Conference Demonstrate Dual Mode of Action 11/6/2012
Kamada Ltd. (KMDA.TA) Announces New Data on its Glassia Drug Supporting Its Diabetes Activities and Treatment of Additional Therapeutic Indications 11/6/2012
Compugen Ltd. (CGEN) Announces Discovery of Two Novel Immune Checkpoint Targets for Cancer Immunotherapy 10/31/2012
MiReven Announces Positive Preclinical Results for miR-7 in Head and Neck Cancer 10/25/2012
BioDiem Ltd. (BDM.AX) Reports Continued Progress in Development of Antimicrobial BDM-I 10/18/2012
Cytoo's 2D + Cell Culture Platform Reproduces in Vivo Conditions to Study Tumor Cell Motility 10/17/2012
Circassia Limited Announces Publication of ToleroMune® Cat Allergy Treatment Clinical Results in Journal of Allergy and Clinical Immunology 9/27/2012
Addex Therapeutics (ADXN.SW) mGluR4 Allosteric Modulator Effective in Multiple Sclerosis Model - a Novel Oral Small Molecule Approach for the Treatment of Multiple Sclerosis 9/24/2012
Ablynx and Its Partner Advance Nanobody Candidate ALX-0751 in Pre-Clinical Development 9/21/2012
Intellect Neurosciences, Inc. and Medical Research Council Technology Announce Humanization of Next-Generation Monoclonal Antibody to Amyloid Beta With Reduced Potential for Inflammation in the Brain of Alzheimer's Patients 9/19/2012
Compugen Ltd. (CGEN) Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance 9/10/2012
MorphoSys AG and the University of Melbourne Publish Preclinical Data on the Role of GM-CSF in Inflammatory, Arthritic and Osteoarthritic Pain 9/10/2012
ValiRx Plc Release: VAL201 Update Regarding Breast Cancer Study 9/6/2012
PRANA Biotechnology (PRAN)'s Parkinson's Drug Meets The Michael J. Fox Foundation Development Milestone 8/29/2012
GenKyoTex S.A. s Lead NOX Inhibitor GKT137831 Demonstrates Activity in Models of Liver Fibrosis 8/8/2012
Fruit Flies Light the Way for A*STAR Scientists to Pinpoint Genetic Changes That Spell Cancer 7/30/2012
SuppreMol Begins Development of Anti-IL-3 Monoclonal Antibody to Diagnose and Treat Early Stage Rheumatoid Arthritis 7/27/2012
Rheumatoid Arthritis New Major Clinical Target After Mesoblast Limited Obtains Positive Results in Inflammatory Arthritis 7/24/2012
Addex Therapeutics (ADXN.SW) Announces the Publication of Positive Data on the Efficacy of mGluR4 Positive Allosteric Modulator in Parkinson's Disease Pre-Clinical Models 7/16/2012
Cancer Therapeutics Reveals Proof of Concept for Second Development Drug 7/5/2012
Pharming Group (PHGUF.PK): New Data Published on RUCONEST's Protective Effects After Severe Blood Loss 7/2/2012
Magnet Helps Target Transplanted Iron-Loaded Cells to Key Areas of Heart, INSERM Study 6/29/2012
Compugen Ltd. (CGEN) Announces Validation Results for a Second Potential Immune Checkpoint Target for Cancer Immunotherapy 6/27/2012
IDBS ELN Powers World Class Preclinical Research at the University of Cape Town 6/14/2012
Pantarhei Bioscience Study Findings Demonstrate the Disappearance of Breast Tumours During Treatment With the Human Fetal Estrogen Estetrol 6/6/2012
ValiRx Plc's Late Pre-clinical Study of VAL201 5/29/2012
PRECOS Launches Premium Bespoke Collection of Clinically Relevant Lung in Oncology Models for Drug Discovery 5/29/2012
Sichuan Agricultural University and LC Sciences Uncover the Epigenetics of Obesity 5/29/2012
Sanofi (France) (SAN.PA) to Test Cancer-starving Compound in China in 2013 5/25/2012
Sanofi (France) (SAN.PA) Pins Hope on Cancer-starving Compound 5/25/2012
ChinaBio(R) LLC Release: China Research Team Develops TB/HIV Combination Vaccine 5/24/2012
ProtAffin AG Releases New Preclinical Data for Lead Anti-inflammatory Product PA401 in Inflammatory Lung Disease 5/22/2012
Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Subjects Improved by Pluristem Therapeutics (PSTI)'s PLX Cells 5/15/2012
Bionor Pharma ASA Release: Successful Immunization and Safety Documented in Nasal Administration Study of the HIV Vaccine Vacc-4x Together With Endocine 5/10/2012
Immunocore Limited Release: Revolutionary New Cancer Targeting Technology Described in Nature Medicine 5/7/2012
Mucosis B.V. Announces Publication of Preclinical Data Demonstrating Superior Protection by Mucosally Administered Mimopath®-Based Influenza Vaccines 5/3/2012
Novo Nordisk A/S (NVO) Says Blood Drugs Could Hold Blockbuster Potential 5/2/2012
Compugen Ltd. (CGEN) Announces Initial Validation Results for Two Novel Immunomodulatory Proteins and Further Results for CGEN-15001 4/24/2012
Novartis AG (NVS) Compound Spurs Cartilage in Arthritic Mice 4/9/2012
Ablynx's Partner Shows That a Nanobody Can Elicit Superior Anti-Tumour Efficacy Compared to Conventional Monoclonal Antibody Approaches 4/4/2012
Basilea Pharmaceutica (BSLN.SW) Presents New Research Data on a Biomarker for Its Novel Oncology Drug Candidate BAL101553 at American Association for Cancer Research 4/4/2012
NOXXON Pharma AG's NOX-A12 Delays Glioblastoma Recurrence in Preclinical Model 4/4/2012
Successful Completion of Preclinical Development Studies in Summit Corporation's C. Difficile Program 4/4/2012
Kymab Announces Milestone in Kymouse™ Human Antibody Platform 4/2/2012
Scientists at Singapore Immunology Network, A*STAR, Discover Special Class of Natural Fats That Stimulates Immune Cells to Fight Diseases 4/2/2012
Immune Cells With a Killer Instinct: Tried-and-Tested Anti-Tumor Drug Displays New Effect, Medical University of Vienna Study 3/26/2012
Integrated DNA Technologies Oligos Used to Increase Efficiency of Detecting Genetic Variation 3/19/2012
BrainStorm Cell Therapeutics Inc. Expands Pipeline with the Initiation of a Study for Multiple Sclerosis 3/12/2012
Combination Therapy May Enhance Gemcitabine Activity for Pancreatic Cancer, University of Cambridge Study 2/28/2012
Allied Announces Coridon Pty Ltd to Develop HPV Therapeutic Vaccine 2/28/2012
Nature Release: BrainStorm Cell Therapeutics Inc.'s NurOwn™ Stem Cell Technology Offers Hope for Treating Huntington Disease 2/27/2012
PROLOR Biotech (PBTH) to Present Preclinical Data on Its Long-Acting Clotting Factors VIIa and IX at European Hemophilia Conference 2/23/2012
BioLineRx Ltd. Announces Publication of Pre-Clinical Results Demonstrating Efficacy of BL-7010, an Oral Treatment for Celiac Disease and Gluten Sensitivity 2/21/2012
TCG Lifesciences Announces Nomination of Pre-clinical Development Candidate 2/20/2012
PROLOR Biotech (PBTH) Announces Positive Preclinical Results from Comparative Study of its Long-Acting Clotting Factor VIIa 2/14/2012
Rabies Vaccines With Isconova's Matrix-M™ Adjuvant Launched in Russia 2/8/2012
GENFIT Corp. (ALGFT) Release: Conclusive Results of Regulatory Toxicology Studies With GFT505 2/8/2012